CaMKV Inhibitors
CaMKV inhibitors belong to a class of chemical compounds designed to target and modulate the activity of Calcium/Calmodulin-Dependent Protein Kinase V (CaMKV). CaMKV is a member of the CaMK (Calcium/Calmodulin-Dependent Kinase) family of proteins, which are essential regulators of various cellular processes. These kinases are known for their ability to sense changes in intracellular calcium levels and transduce these signals into phosphorylation events, thereby controlling the activity of downstream target proteins. CaMKV, in particular, is implicated in neuronal function and is predominantly expressed in the brain. Inhibitors of CaMKV are developed to interact with this kinase, disrupting its phosphorylation activities and affecting the signaling pathways it governs.
CaMKV inhibitors are typically small molecules or compounds designed to bind to CaMKV, interfering with its ability to phosphorylate downstream targets or to be activated by calcium/calmodulin. By doing so, these inhibitors may modulate the cellular responses and signaling pathways that involve CaMKV. Research into CaMKV inhibitors is crucial for understanding the molecular mechanisms by which this kinase contributes to neuronal function and other cellular processes. Insights into the regulation of CaMKV activity can provide valuable knowledge about calcium signaling in neurons and may have implications for neurological research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a well-known inhibitor of CaMKII, and due to the similarity in kinases, it might also affect CaMKV expression by inhibiting its kinase activity. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
STO-609 is an inhibitor of CaMKK, which is upstream of CaMKV, and may indirectly inhibit CaMKV expression by blocking its activation. | ||||||
Myricetin | 529-44-2 | sc-203147 sc-203147A sc-203147B sc-203147C sc-203147D | 25 mg 100 mg 1 g 25 g 100 g | $97.00 $188.00 $260.00 $510.00 $1022.00 | 3 | |
Myricetin is a flavonoid with kinase inhibitory properties and may nonspecifically inhibit CaMKV activity, leading to reduced expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium has been shown to inhibit GSK-3beta, which could play a role in the regulation of CaMKV expression in neuronal cells. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Although a p38 MAPK inhibitor, SB 203580 might affect CaMKV expression given the cross-talk between MAPK and CaMK pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor and could reduce CaMKV expression due to the involvement of PI3K in various signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in protein synthesis; this could theoretically decrease CaMKV protein levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This MEK inhibitor can affect MAPK/ERK pathways which have potential interactions with CaMKV expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that could affect CaMKV expression through modulating PI3K/Akt signaling pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, and the JNK pathway has been implicated in various cellular processes that might influence CaMKV expression. | ||||||